Relmada Therapeutics, Inc. (FRA:4E2)
Germany · Delayed Price · Currency is EUR 3.240
+0.060 (1.89%)
At close: Jan 27, 2026
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of €219.12 million as of January 30, 2026. Its market cap has increased by 1,784.47% in one year.
Market Cap
219.12M
Enterprise Value
207.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.24
Market Cap Chart
Since June 20, 2014, Relmada Therapeutics's market cap has increased from 88.97M to 219.12M, an increase of 146.28%. That is a compound annual growth rate of 8.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 219.12M | -27.36% |
| Dec 31, 2025 | 301.67M | 1,890.52% |
| Dec 31, 2024 | 15.16M | -86.56% |
| Dec 29, 2023 | 112.74M | 14.69% |
| Dec 30, 2022 | 98.29M | -82.11% |
| Dec 31, 2021 | 549.27M | 29.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novabase S.G.P.S. | 350.97M |
| SIMONA Aktiengesellschaft | 300.00M |
| EUWAX Aktiengesellschaft | 267.80M |
| centrotherm international AG | 241.25M |
| STINAG Stuttgart Invest AG | 232.23M |
| Sino AG | 229.08M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 208.56M |
| Allane SE | 204.05M |